Cargando…
Cardiovascular Safety of Celecoxib on Top of Dual Antiplatelet Therapy
Autor principal: | Hong, Bum-Kee |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2910285/ https://www.ncbi.nlm.nih.gov/pubmed/20664737 http://dx.doi.org/10.4070/kcj.2010.40.7.306 |
Ejemplares similares
-
Celecoxib Does Not Attenuate the Antiplatelet Effects of Aspirin and Clopidogrel in Healthy Volunteers
por: Lee, Wonjae, et al.
Publicado: (2010) -
Safety of tirofiban and dual antiplatelet therapy in treating intracranial aneurysms
por: Samaniego, Edgar A, et al.
Publicado: (2019) -
Optimizing the Duration of Dual Antiplatelet Therapy After Implantation of Drug-eluting Coronary Stents
por: Shen, Ying, et al.
Publicado: (2015) -
Dual antiplatelet therapy and newer agents: More efficacy but lets keep the brain safe!!
por: Bhatia, Rohit, et al.
Publicado: (2015) -
Safety of Percutaneous Dilatational Tracheotomy in Patients on Dual Antiplatelet Therapy and Anticoagulation
por: Lüsebrink, Enzo, et al.
Publicado: (2019)